The effect of proton pump inhibitors on glycated hemoglobin levels in patients with type 2 diabetes mellitus (Q38259154)

1 September 2017

title

The effect of proton pump inhibitors on glycated hemoglobin levels in patients with type 2 diabetes mellitus (English)

1 reference

1 September 2017

1 reference

1 reference

glycated hemoglobin

23 October 2023

Tae Kyoon Kim

6

0 references

author name string

Na Han

1

1 reference

1 September 2017

Minkyung Oh

2

1 reference

1 September 2017

Su Min Park

3

1 reference

1 September 2017

You Jeong Kim

4

1 reference

1 September 2017

Eun Ju Lee

5

1 reference

1 September 2017

Tae Nyun Kim

7

1 reference

1 September 2017

Min Jeong Kwon

8

1 reference

1 September 2017

Mi-Kyung Kim

9

1 reference

1 September 2017

Soon Hee Lee

10

1 reference

1 September 2017

Byoung Doo Rhee

11

1 reference

1 September 2017

Jeong Hyun Park

12

1 reference

1 September 2017

publication date

8 October 2014

1 reference

Canadian Journal of Diabetes

1 September 2017

published in

1 reference

1 September 2017

volume

39

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

24-28

1 reference

Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis

1 September 2017

cites work

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Influence of esomeprazole on hypoglycemic activity of oral antidiabetic agents in rats and rabbits

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Proton pump inhibitors as a treatment method for type II diabetes

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Pantoprazole improves glycemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled trial.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Long-term proton pump inhibitor therapy and risk of hip fracture

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Proton pump inhibitor therapy associated with lower glycosylated hemoglobin levels in type 2 diabetes

2 references

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.3122/JABFM.2012.01.100161

Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Proton pump inhibitors: impact on glucose metabolism

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients - a retrospective analysis

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Gastrin: old hormone, new functions

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Influence of aging on gastric ulcer healing activities of cimetidine and omeprazole

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Combination Therapy with a Dipeptidyl Peptidase-4 Inhibitor and a Proton Pump Inhibitor Induces β-Cell Neogenesis from Adult Human Pancreatic Duct Cells Implanted in Immunodeficient Mice

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

The physiology of gastric acid secretion

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JCJD.2013.10.008

Identifiers

DOI

10.1016/J.JCJD.2013.10.008

1 reference

1 September 2017

1 reference